Europe Pharmaceuticals & Healthcare Products (39)
-
Belarus Pharmaceuticals & Healthcare Report
Pub date: 19 Apr 2012 Europe / Belarus Pharmaceuticals & Healthcare Industry Report
BMI View: We continue to believe the Belarusian pharmaceutical market has long-term potential due to the country's favourable geographic position, demographic profile and low per capita spending. No... Read MoreWeb Price: $995 -
Belgium Pharmaceuticals & Healthcare Report
Pub date: 02 Mar 2012 Europe / Belgium Pharmaceuticals & Healthcare Industry Report
BMI View: Belgium, much like most of the other regional markets, is expected to post negative year-onyear (y-o-y) value growth in its 2012 pharmaceutical sales because of patent expirations and the ... Read MoreWeb Price: $995 -
Bulgaria Pharmaceuticals & Healthcare Report
Pub date: 02 Mar 2012 Europe / Bulgaria Pharmaceuticals & Healthcare Industry Report
BMI View: Bulgaria's pharmaceutical market will be under some pressure in 2012 due to a weakening economic outlook and the tightening of publicly funded healthcare services. However, we have broadly ... Read MoreWeb Price: $995 -
Burden Of Disease Database
Pub date: 29 Sep 2008 Global / Middle East Pharmaceuticals & Healthcare Special Report
Key insights from BMI’s Burden of Disease Database, an online tool that forecasts the burden of 123 diseases in 192 countries through to 2030.... Read MoreWeb Price: $490 -
Contract Research Organisations: The Strengths And Challenges Of An Evolving Industry
Pub date: 27 Feb 2012 Global Pharmaceuticals & Healthcare Special Report
There has been strong appetite from private equity to acquire contract research organisations (CROs) throughout 2011. The spate of acquisitions comes at a time when the industry is undergoing a c... Read MoreWeb Price: $490 -
Croatia Pharmaceuticals & Healthcare Report
Pub date: 19 Mar 2012 Europe / Croatia Pharmaceuticals & Healthcare Industry Report
BMI View: Based on Croatia's deteriorating macroeconomic outlook, combined with our expectations that the new Kukuriku coalition government will pursue more severe austerity measures and the fact th... Read MoreWeb Price: $995 -
Czech Republic Pharmaceuticals & Healthcare Report
Pub date: 05 Apr 2012 Europe / Czech Republic Pharmaceuticals & Healthcare Industry Report
BMI View: We retain our negative outlook for the pharmaceutical market in the Czech Republic, expecting a 1.8% contraction in its value in local currency terms in 2012, following the 1.0% year-onyear... Read MoreWeb Price: $995 -
Estonia Pharmaceuticals & Healthcare Report
Pub date: 24 Feb 2012 Europe / Estonia Pharmaceuticals & Healthcare Industry Report
BMI View: Estonia’s pharmaceutical market will remain of marginal interest to multinationals, given its small population size and a modest growth outlook. We expect the market to post a five-year com... Read MoreWeb Price: $995 -
Eurozone Debt Crisis: Effects on PIIGS Pharmaceuticals Market
Pub date: 24 May 2010 Global / Middle East Pharmaceuticals & Healthcare Special Report
In this report, BMI provides an analysis of the implications of the Eurozone sovereign debt crisis on the PIIGS pharmaceutical industries, with a particular focus on the impact of the austerity measur... Read MoreWeb Price: $490 -
France Pharmaceuticals & Healthcare Report
Pub date: 02 Mar 2012 Europe / France Pharmaceuticals & Healthcare Industry Report
BMI View: Despite concerted progress made on the fiscal consolidation front in the first half of 2011, the French government's medium-term fiscal targets remain on the optimistic side, particularly g... Read MoreWeb Price: $995 -
Germany Pharmaceuticals & Healthcare Report
Pub date: 28 Feb 2012 Europe / Germany Pharmaceuticals & Healthcare Industry Report
BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare sector, as well as the impact of generic competition as a r... Read MoreWeb Price: $995 -
Global Economic Downturn: Implications For The Pharmaceutical Industry
Pub date: 16 Sep 2009 Global / North America Pharmaceuticals & Healthcare Special Report
In this special report, BMI assess the impact of the economic downturn on drug expenditure levels in markets across the globe.... Read MoreWeb Price: $490 -
Greece Pharmaceuticals & Healthcare Report
Pub date: 05 Apr 2012 Europe / Greece Pharmaceuticals & Healthcare Industry Report
BMI View: The challenges facing drugmakers in Greece in 2012 will be considerably tougher than those faced in 2011. With the introduction of new cost-containment legislation in March 2012, the Greek ... Read MoreWeb Price: $995 -
Hungary Pharmaceuticals & Healthcare Report
Pub date: 17 Feb 2012 Europe / Hungary Pharmaceuticals & Healthcare Industry Report
BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical market, representing moderately good news for drugmakers. However, this development wi... Read MoreWeb Price: $995 -
Italy Pharmaceuticals & Healthcare Report
Pub date: 17 Feb 2012 Europe / Italy Pharmaceuticals & Healthcare Industry Report
BMI View: The pharmaceuticals and healthcare sector will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highl... Read MoreWeb Price: $995 -
Kazakhstan Pharmaceuticals & Healthcare Report
Pub date: 02 Mar 2012 Europe / Kazakhstan Pharmaceuticals & Healthcare Industry Report
BMI View: Kazakhstan remains the most accessible and competitive pharmaceutical market in Central Asia and the growing expectation it will gain World Trade Organisation (WTO) membership by the end o... Read MoreWeb Price: $995 -
Latvia Pharmaceuticals & Healthcare Report
Pub date: 04 May 2012 Europe / Latvia Pharmaceuticals & Healthcare Industry Report
BMI View: We have revised downwards our 2012 projections for the growth of the Latvian pharmaceutical market on account of weaker growth towards the end of 2011, combined with ongoing concerns over ... Read MoreWeb Price: $995 -
Lithuania Pharmaceuticals & Healthcare Report
Pub date: 13 Apr 2012 Europe / Lithuania Pharmaceuticals & Healthcare Industry Report
BMI View: Lithuania's drug market is expected to post a gradual recovery over the next five years, but with a short-term worsening economic environment. Public and private consumption will be under ... Read MoreWeb Price: $995 -
Moldova Pharmaceuticals & Healthcare Report
Pub date: 16 Mar 2012 Europe / Moldova Pharmaceuticals & Healthcare Industry Report
BMI View: Moldova's pharmaceutical market recorded stronger growth in 2011, but its small market size and its status as the poorest countries in Europe limit its attractiveness as a destination for ... Read MoreWeb Price: $995 -
Molybdenum-99: Privatising Nuclear Medicine
Pub date: 08 Jun 2011 Global Pharmaceuticals & Healthcare Special Report
This Special Report from Business Monitor International (BMI) examines the global supply of Molybdenum- 99, looking at the likelihood of price rises and the implications of investment. The report i... Read MoreWeb Price: $490 -
Multinational Pharmaceuticals Companies in Emerging Europe CD-ROM
Pub date: 01 Jan 2012 Global / Europe Pharmaceuticals & Healthcare Multinational Companies Industry Directory
Multinational Pharmaceuticals Companies in Europe CD-ROM... Read MoreWeb Price: $995 -
Netherlands Pharmaceuticals & Healthcare Report
Pub date: 11 May 2012 Europe / Netherlands Pharmaceuticals & Healthcare Industry Report
BMI View: While the Netherlands is a low risk market from the point of view of multinational drugmakers, the country's modest per capita expenditure on pharmaceuticals relative to other Western Euro... Read MoreWeb Price: $995 -
Pharmaceutical Pricing: Dynamics In A Global Market
Pub date: 19 Apr 2010 Global Pharmaceuticals & Healthcare Special Report
BMI analyses pharmaceutical consumer price indices across 40 countries, identifying historic and likely future trends in pricing policies and dynamics.... Read MoreWeb Price: $490 -
Poland Pharmaceuticals & Healthcare Report
Pub date: 02 Mar 2012 Europe / Poland Pharmaceuticals & Healthcare Industry Report
BMI View: It is worth reiterating our view that while 2012 is set to be a challenging year for drugmakers operating in Poland, we do not believe the impact of the Drug Reimbursement Act will lead to ... Read MoreWeb Price: $995 -
Portugal Pharmaceuticals & Healthcare Report
Pub date: 16 Mar 2012 Europe / Portugal Pharmaceuticals & Healthcare Industry Report
BMI View: Since the approval of an EU/ECB/IMF economic rescue package in May 2011, cost cutting measures have taken their toll on all sectors - including the pharmaceutical and healthcare industry. F... Read MoreWeb Price: $995 -
Romania Pharmaceuticals & Healthcare Report
Pub date: 16 Mar 2012 Europe / Romania Pharmaceuticals & Healthcare Industry Report
BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare sector. In particular, draf... Read MoreWeb Price: $995 -
Russia Pharmaceuticals & Healthcare Report
Pub date: 22 Mar 2012 Europe / Russia Pharmaceuticals & Healthcare Industry Report
BMI View: On the positive side, Russia's pharmaceutical market should regain double-digit US dollar growth from 2013 and the approval of the country's entry to the WTO should provide a clearer regul... Read MoreWeb Price: $995 -
Serbia Pharmaceuticals & Healthcare Report
Pub date: 22 Mar 2012 Europe / Serbia Pharmaceuticals & Healthcare Industry Report
BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical industry is particularly... Read MoreWeb Price: $995 -
Slovakia Pharmaceuticals & Healthcare Report
Pub date: 03 Apr 2012 Europe / Slovakia Pharmaceuticals & Healthcare Industry Report
BMI View: The Slovakian pharmaceutical market will be shaped by the introduction of new, strict costcontainment measures, which include legislation designed to significantly lower drug prices. The p... Read MoreWeb Price: $995 -
Slovenia Pharmaceuticals & Healthcare Report
Pub date: 17 Feb 2012 Europe / Slovenia Pharmaceuticals & Healthcare Industry Report
BMI View: Slovenia's pharmaceutical market outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised forecasts have led us to adjust our drug market projections ... Read MoreWeb Price: $995 -
Spain Pharmaceuticals & Healthcare Report
Pub date: 16 Mar 2012 Europe / Spain Pharmaceuticals & Healthcare Industry Report
BMI View: Companies with significant exposure to debt-ridden European markets will be hard hit by government austerity measures across the region, particularly by pharmaceutical price erosion mechan... Read MoreWeb Price: $995 -
Sweden Pharmaceuticals & Healthcare Report
Pub date: 04 May 2012 Europe / Sweden Pharmaceuticals & Healthcare Industry Report
BMI View: Our five-year forecasts for the Swedish pharmaceutical market show a decline in its overall size, which is expected to fall to SEK42.02bn (US$5.64bn) by 2016. Key reasons for this pessimism... Read MoreWeb Price: $995 -
Switzerland Pharmaceuticals & Healthcare Report
Pub date: 16 Mar 2012 Europe / Switzerland Pharmaceuticals & Healthcare Industry Report
BMI View: The expected growth of the Switzerland's ageing population over the next 50 years will have an unprecedented impact on the demand for healthcare. The elderly require more medical check-ups ... Read MoreWeb Price: $995 -
The Opportunities Of African Healthcare: What China's Entry Means For Multinationals
Pub date: 14 Feb 2012 Global Pharmaceuticals & Healthcare Special Report
This Special Report from Business Monitor International (BMI) examines the African healthcare and pharmaceutical markets, looking at the opportunities and characteristics primarily of the sub-Sahar... Read MoreWeb Price: $490 -
Turkey Pharmaceuticals & Healthcare Report
Pub date: 11 May 2012 Europe / Turkey Pharmaceuticals & Healthcare Industry Report
BMI View: Before 2010, Turkey's pharmaceutical market growth was rapidly driven by modernisation, growing investment and improving awareness about healthcare. Since 2009, Turkey's pharmaceutical ind... Read MoreWeb Price: $995 -
Ukraine Pharmaceuticals & Healthcare Report
Pub date: 22 Mar 2012 Europe / Ukraine Pharmaceuticals & Healthcare Industry Report
BMI View: While we continue to see huge potential in the Ukrainian pharmaceutical market, we are pessimistic with regard to short- and medium-term stability in the marketplace. In particular, we are ... Read MoreWeb Price: $995 -
United Kingdom Pharmaceuticals & Healthcare Report
Pub date: 05 Apr 2012 Europe / United Kingdom Pharmaceuticals & Healthcare Industry Report
BMI View: While the strength of the UK's pharmaceutical manufacturing industry is significant, the sector will face considerable challenges over the coming years. Economic weakness, patent expiration... Read MoreWeb Price: $995 -
US Regulatory Trends During 2010: A Rapidly Changing Environment
Pub date: 25 Jan 2011 Global / North America Pharmaceuticals & Healthcare Special Report
BMI’s analysis of regulatory approvals in 2010 says much about which drugmakers will outperform rivals throughout 2011, with biological blockbuster drugs leading the way.... Read MoreWeb Price: $490 -
Uzbekistan Pharmaceuticals & Healthcare Report
Pub date: 17 Feb 2012 Europe / Uzbekistan Pharmaceuticals & Healthcare Industry Report
BMI View: Uzbekistan is Central Asia’s largest market by population, although its pharmaceutical market lags that of neighbouring Kazakhstan in value terms, with per capita spending on pharmaceutica... Read MoreWeb Price: $995